Health Impact

Health impact is a vital element in the scope of the Sustainable Development Goals (SDGs). The term "health impact" refers to the effect of a specific action, policy, or environmental change on the health of individuals and communities. It is widely used in health impact assessments, which aim to predict the potential health outcomes of a proposed policy or project.

With reference to the SDGs, health impact is chiefly aligned with SDG 3: "Ensure healthy lives and promote well-being for all at all ages". This goal envisages a world where every individual has access to quality healthcare services and lives devoid of preventable diseases. Such a scenario necessitates careful consideration and evaluation of the health impacts of all developmental policies, programs, and interventions.

However, the relevance of health impact extends beyond SDG 3. For example, the implementation of SDG 11: "Make cities and human settlements inclusive, safe, resilient, and sustainable" can have a significant health impact. By promoting sustainable urban planning, we can reduce air pollution, promote physical activity, and decrease mental stress, thereby positively affecting public health.

Similarly, the realization of SDG 6: "Ensure availability and sustainable management of water and sanitation for all" directly influences the health impact by reducing waterborne diseases and improving hygiene. SDG 2: "End hunger, achieve food security and improved nutrition and promote sustainable agriculture" also has direct health impacts by improving nutritional outcomes.

September 2023 marks the 12th anniversary of World Alzheimer’s Month, our international campaign to raise awareness and challenge stigma. In 2022, over 111 countries took part in advocacy, fundraising and awareness raising events for World Alzheimer’s Month, with many working to raise general awareness and call for further support for those most affected in their communities. The month of activities shows a truly global, regional, national and local level response to promote dementia awareness and what we can do to help support those living with the disease, now and in the future.

On the occasion of World Hepatitis Day 2023, this "World We Want" podcast episode focuses on the public health threat of hepatitis and the urgent need to address it to achieve SDG3: Good Health and Well-Being. Here, Márcia Balisciano speaks to Rob Brierley, Editor-in-Chief of The Lancet Gastroenterology & Hepatology to understand the ongoing challenges to achieving this goal, including medical, infrastructural, financial, and other roadblocks.
Elsevier,

Brain Responses to Auditory Mismatch and Novelty Detection, First Edition, 2023, pp 271-314

This chapter advances the UN SDG goals 3 and 17 understanding whether decreasing network connectivity in aging is independent of changes across cognitive networks or is accelerated by mild cognitive impairment and AD.
In this episode of the “World We Want” podcast series, the editors of the new book Oceans and Human Health: Opportunities and Impacts talk to Márcia Balisciano about about the fascinating connections between the ocean and human health, spanning from wellbeing and mental health, to medicinal resources, plastics, food and nutrition, and the health risks of polluted oceans.
Elsevier,

Clinical Neuroepidemiology of Acute and Chronic Disorders, First Edition, 2023, pp 199-211

This chapter advances the UN SDG goals 3 and 17 by reviewing the basics understandings of delirium and dementia.
This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 259-271

This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.
Elsevier,

COVID-19 in Alzheimer's Disease and Dementia, First Edition, 2023, pp 203-214

This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.
Elsevier,

Medicinal Usage of Cannabis and Cannabinoids, First Edition, 2023, pp 129-134

This chapter advances the UN SDG goals 3 and 17 by reviewing the use of cannabidiol oil for AD patients.
Elsevier,

Handbook of Animal Models in Neurological Disorders, First Edition, 2022, pp 31-41

This chapter advances the UN SDG goals 3 and 17 presenting the current mouse models to studying AD.

Pages